OPKO Health (NASDAQ:OPK) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.11) by 35.78 percent. This is a 600 percent decrease over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $156.800 million which missed the analyst consensus estimate of $165.744 million by 5.40 percent. This is a 13.94 percent decrease over sales of $182.200 million the same period last year.